|
MRPS27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.039900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.848400E-02 |
| Normal-vs-Stage2 |
2.717800E-01 |
| Normal-vs-Stage3 |
9.299500E-03 |
| Normal-vs-Stage4 |
4.239400E-03 |
| Stage1-vs-Stage2 |
5.339600E-03 |
| Stage1-vs-Stage3 |
3.011200E-01 |
| Stage1-vs-Stage4 |
2.430200E-01 |
| Stage2-vs-Stage3 |
7.230300E-04 |
| Stage2-vs-Stage4 |
1.400300E-03 |
| Stage3-vs-Stage4 |
8.710200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.481520E-02 |
| Normal-vs-AfricanAmerican |
2.849000E-01 |
| Normal-vs-Asian |
4.673900E-02 |
| Caucasian-vs-AfricanAmerican |
5.114600E-01 |
| Caucasian-vs-Asian |
7.819400E-01 |
| AfricanAmerican-vs-Asian |
6.113600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.716000E-02 |
| Normal-vs-Female |
3.908000E-02 |
| Male-vs-Female |
9.366200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.884230E-02 |
| Normal-vs-Age(41-60Yrs) |
2.940200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.867800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.086600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.059200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.466970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.272600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.866600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.759600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.628800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.218400E-02 |
| Classical-VS-Follicular |
1.968150E-02 |
| Classical-VS-Other |
7.721600E-01 |
| Classical-VS-Normal |
1.904060E-02 |
| Tall-VS-Follicular |
7.166400E-04 |
| Tall-VS-Other |
4.750800E-01 |
| Tall-VS-Normal |
5.971600E-04 |
| Follicular-VS-Other |
3.608200E-01 |
| Follicular-VS-Normal |
8.723800E-01 |
| Other-VS-Normal |
2.391000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.281000E-01 |
| Normal-vs-N1 |
6.4180999999941E-05 |
| N0-vs-N1 |
1.382940E-03 |
|
|
